Enhancing cancer care with improved checkpoint inhibitors

Enhancing cancer care with improved checkpoint inhibitors

The emergence of checkpoint inhibitors targeting the PD-1/PD-L1 axis marks a paradigm shift in cancer therapy, offering a novel avenue for enhancing patient outcomes. This review examines the structural and functional dynamics of PD-1 and PD-L1 while exploring the clinical implications of current PD...

Full description

Saved in:
Bibliographic Details
Main Authors: Vickram A S, Saghya Infant Shofia, A. Saravaran, Vidhya Lakshmi Sivakumar, Packiyam Thamarai, Manikandan Sivasubramanian, Shivani Chopra, Hitesh Chopra
Format: Article
Language:English
Published: IfADo - Leibniz Research Centre for Working Environment and Human Factors, Dortmund 2024-10-01
Series:EXCLI Journal : Experimental and Clinical Sciences
Subjects:
checkpoint inhibitors
pd-1
pd-l1
cancer
immunotherapy
Online Access:https://www.excli.de/excli/article/view/7783
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.excli.de/excli/article/view/7783

Similar Items